October 16-17, 2024

American Society of Gene & Cell Therapy (ASGCT) Advancing Gene and Cell Therapies for Cancer Conference

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer, presented “Engineering G proteins on lentiviral vectors for T-cell targeted in vivo delivery of CAR constructs” at the ASGCT Advancing Gene and Cell Therapies for Cancer conference in Philadelphia.  Kah-Whye Peng, Ph.D., Vyriad Chief Technical Officer attended the ASGCT Advancing Gene and Cell Therapies for Cancer conference in Philadelphia.